Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Say-yed Hesameddin Tafreshi. (2020) Efficacy, safety, and formulation issues of the combined vaccines. Expert Review of Vaccines 19:10, pages 949-958.
Read now
Read now
Nicolas Lecrenier, Pierre Beukelaers, Romulo Colindres, Desmond Curran, Carine De Kesel, Jean-Philippe De Saegher, Arnaud M Didierlaurent, Edouard Y Ledent, Johann F Mols, Tomas Mrkvan, Marie Normand-Bayle, Lidia Oostvogels, Fernanda Tavares Da Silva, Ventzislav Vassilev, Carlota Vinals & Alain Brecx. (2018) Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Review of Vaccines 17:7, pages 619-634.
Read now
Read now
Articles from other publishers (20)
Lidan Hu, Jingmiao Sun, Yan Wang, Danny Tan, Zhongkai Cao, Langping Gao, Yuelin Guan, Xiuwei Jia & Jianhua Mao. (2023) A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations. Vaccines 11:6, pages 1045.
Crossref
Crossref
Jilan A. Nazeam & Abdel Nasser B. Singab. (2022) Immunostimulant plant proteins: Potential candidates as vaccine adjuvants. Phytotherapy Research 36:12, pages 4345-4360.
Crossref
Crossref
Diego A. Díaz-Dinamarca, Michelle L. Salazar, Byron N. Castillo, Augusto Manubens, Abel E. Vasquez, Fabián Salazar & María Inés Becker. (2022) Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities. Pharmaceutics 14:8, pages 1671.
Crossref
Crossref
Allison August, Luis Brito, Robert Paris & Tal Zaks. 2022. mRNA Vaccines. mRNA Vaccines
167
186
.
Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, Margherita Coccia & Giuseppe Lofano. (2021) “World in motion” – emulsion adjuvants rising to meet the pandemic challenges. npj Vaccines 6:1.
Crossref
Crossref
Fernanda Tavares-Da-Silva, Olivia Mahaux, Lionel Van Holle, François Haguinet, Harry Seifert & Jens-Ulrich Stegmann. (2020) Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology. Drug Safety 43:12, pages 1223-1234.
Crossref
Crossref
Suvi Heinimäki, Kirsi Tamminen, Vesa P. Hytönen, Maria Malm & Vesna Blazevic. (2020) Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only. Vaccines 8:3, pages 365.
Crossref
Crossref
Lisa Weitz, Luise Bellach, Alicia Faltum, Angelika Berger & Wolfgang Maurer. (2020) Vaccine hesitancy. Wiener klinische Wochenschrift 132:9-10, pages 243-252.
Crossref
Crossref
Stanley A. Plotkin, Paul A. Offit, Frank DeStefano, Heidi J. Larson, Narendra Kumar Arora, Patrick L.F. Zuber, Eric Fombonne, James Sejvar, Paul Henri Lambert, Anders Hviid, Neal Halsey, Nathalie Garçon, Keith Peden, Andrew J. Pollard, Lauri E. Markowitz & Jason Glanz. (2020) The science of vaccine safety: Summary of meeting at Wellcome Trust. Vaccine 38:8, pages 1869-1880.
Crossref
Crossref
Kirsi Tamminen, Suvi Heinimäki, Timo Vesikari & Vesna Blazevic. (2020) Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo. Journal of Immunology Research 2020, pages 1-14.
Crossref
Crossref
Damiana Téllez-Martínez, Alexander Batista-Duharte, Deivys Leandro Portuondo & Iracilda Zeppone Carlos. (2019) Prophylactic and therapeutic vaccines against sporotrichosis. Feasibility and prospects. Microbes and Infection 21:10, pages 432-440.
Crossref
Crossref
Béatrice Laupèze, Caroline Hervé, Alberta Di Pasquale & Fernanda Tavares Da Silva. (2019) Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood. Vaccine 37:38, pages 5670-5680.
Crossref
Crossref
Catherine Cohet, Robbert van der Most, Vincent Bauchau, Rafik Bekkat-Berkani, T. Mark Doherty, Anne Schuind, Fernanda Tavares Da Silva, Rino Rappuoli, Nathalie Garçon & Bruce L. Innis. (2019) Safety of AS03-adjuvanted influenza vaccines: A review of the evidence. Vaccine 37:23, pages 3006-3021.
Crossref
Crossref
Zhong-Fang Liu, Jun-Lan Chen, Wu-You Li, Ming-Wen Fan & Yu-Hong Li. (2019) FimH as a mucosal adjuvant enhances persistent antibody response and protective efficacy of the anti-caries vaccine. Archives of Oral Biology 101, pages 122-129.
Crossref
Crossref
Yohei Takeda, Hiromi Takaki, Aya Fukui-Miyazaki, Sumito Yoshida, Misako Matsumoto & Tsukasa Seya. (2018) Vaccine adjuvant ARNAX promotes mucosal IgA production in influenza HA vaccination. Biochemical and Biophysical Research Communications.
Crossref
Crossref
Sonali Kochhar, Jan Bonhoeffer, Christine E. Jones, Flor M. Muñoz, Angel Honrado, Jorgen Bauwens, Ajoke Sobanjo-ter Meulen & Steven Hirschfeld. (2017) Immunization in pregnancy clinical research in low- and middle-income countries – Study design, regulatory and safety considerations. Vaccine 35:48, pages 6575-6581.
Crossref
Crossref
Labdhi Seth, Karen M. Bingham Ferlez, Stephen A. Kaba, Derek M. Musser, Sharareh Emadi, Gary R. Matyas, Zoltan Beck, Carl R. Alving, Peter Burkhard & David E. Lanar. (2017) Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants. Vaccine 35:41, pages 5448-5454.
Crossref
Crossref
Catherine Cohet, Dominique Rosillon, Corinne Willame, Francois Haguinet, Marie-Noëlle Marenne, Sandrine Fontaine, Hubert Buyse, Vincent Bauchau & Laurence Baril. (2017) Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view. Vaccine 35:23, pages 3041-3049.
Crossref
Crossref
Scott Preiss, Nathalie Garçon, Anthony L. Cunningham, Richard Strugnell & Leonard R. Friedland. (2016) Vaccine provision: Delivering sustained & widespread use. Vaccine 34:52, pages 6665-6671.
Crossref
Crossref
Louise Brinth. (2015) Is Chronic Fatigue Syndrome/Myalgic Encephalomyelitis a Relevant Diagnosis in Patients with Suspected Side Effects to Human Papilloma Virus Vaccine?. International Journal of Vaccines & Vaccination 1:1.
Crossref
Crossref